US Stock MarketDetailed Quotes

ELYM Eliem Therapeutics

Watchlist
  • 3.980
  • +0.590+17.40%
Close Apr 26 16:00 ET
  • 4.120
  • +0.140+3.52%
Post 19:56 ET
110.32MMarket Cap-3061P/E (TTM)

Eliem Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
44.88%-20.6M
88.79%-947K
183.59%3.49M
42.97%-7.97M
-40.80%-15.18M
-3.60%-37.37M
-7.17%-8.45M
67.80%-4.18M
-64.67%-13.97M
-59.93%-10.78M
Net income from continuing operations
22.38%-35.12M
53.09%-3.64M
59.02%-3.97M
64.24%-5.22M
-68.81%-22.29M
4.71%-45.24M
26.39%-7.76M
-0.70%-9.68M
-67.40%-14.6M
29.01%-13.2M
Operating gains losses
-174.51%-304K
118.21%330K
-100.40%-4K
-137.96%-399K
-230.51%-231K
266.53%408K
---1.81M
1,355.70%992K
1,336.47%1.05M
318.52%177K
Other non cash items
-8.58%405K
-23.68%87K
-23.21%86K
0.92%110K
12.96%122K
-96.22%443K
--114K
--112K
--109K
-99.08%108K
Change In working capital
1,692.38%3.76M
393.60%1.42M
177.81%7.47M
-11.24%-2.67M
-705.42%-2.46M
105.03%210K
-139.67%-484K
158.58%2.69M
-230.40%-2.4M
656.16%406K
-Change in prepaid assets
679.89%7.37M
663.50%1.54M
1,648.01%6.61M
-3.19%-809K
-98.97%25K
109.21%945K
-132.50%-274K
94.15%-427K
76.45%-784K
605.20%2.43M
-Change in payables and accrued expense
-1,346.93%-3.3M
98.47%-2K
49.24%-633K
-278.97%-1.32M
-425.67%-1.35M
-106.48%-228K
-129.77%-131K
-905.65%-1.25M
-55.20%737K
-73.47%413K
-Change in other current assets
291.67%115K
-91.67%1K
-63.42%1.64M
81.52%-409K
52.34%-1.12M
-102.34%-60K
117.14%12K
58.90%4.49M
-331.24%-2.21M
-104.35%-2.35M
-Change in other current liabilities
5.59%-422K
-34.07%-122K
-16.80%-146K
4.93%-135K
78.65%-19K
-6,485.71%-447K
-1,400.00%-91K
---125K
---142K
---89K
Cash from discontinued investing activities
Operating cash flow
44.88%-20.6M
88.79%-947K
183.59%3.49M
42.97%-7.97M
-40.80%-15.18M
-3.60%-37.37M
-7.17%-8.45M
67.80%-4.18M
-64.67%-13.97M
-59.93%-10.78M
Investing cash flow
Cash flow from continuing investing activities
100.29%68.98M
157.37%36.75M
229.50%28.04M
-110.21%-1.6M
243.67%5.8M
129.96%34.44M
277.34%14.28M
107.96%8.51M
15.69M
-4.04M
Net investment purchase and sale
100.29%68.98M
157.37%36.75M
229.50%28.04M
-110.21%-1.6M
243.67%5.8M
129.96%34.44M
277.34%14.28M
107.96%8.51M
--15.69M
---4.04M
Cash from discontinued investing activities
Investing cash flow
100.29%68.98M
157.37%36.75M
229.50%28.04M
-110.21%-1.6M
243.67%5.8M
129.96%34.44M
277.34%14.28M
107.96%8.51M
--15.69M
---4.04M
Financing cash flow
Cash flow from continuing financing activities
841K
288K
528K
24K
1K
0
0
0
0
0
Proceeds from stock option exercised by employees
--841K
--288K
--528K
--24K
--1K
--0
--0
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
--841K
--288K
--528K
--24K
--1K
--0
--0
--0
--0
--0
Net cash flow
Beginning cash position
-7.11%43.59M
59.56%57.35M
-22.42%25.29M
7.85%34.44M
-7.11%43.59M
129.03%46.92M
-42.78%35.94M
-67.23%32.6M
-33.35%31.93M
129.03%46.92M
Current changes in cash
1,780.54%49.22M
519.13%36.09M
639.62%32.06M
-654.12%-9.54M
36.69%-9.38M
-111.18%-2.93M
136.67%5.83M
111.80%4.33M
-96.66%1.72M
-154.18%-14.81M
Effect of exchange rate changes
174.51%304K
-118.21%-330K
100.40%4K
137.96%399K
230.51%231K
-266.53%-408K
--1.81M
-1,355.70%-992K
-1,336.47%-1.05M
-318.52%-177K
End cash Position
113.63%93.11M
113.63%93.11M
59.56%57.35M
-22.42%25.29M
7.85%34.44M
-7.11%43.59M
-7.11%43.59M
-42.78%35.94M
-67.23%32.6M
-33.35%31.93M
Free cash flow
44.88%-20.6M
88.79%-947K
183.59%3.49M
42.97%-7.97M
-40.80%-15.18M
-3.60%-37.37M
-7.17%-8.45M
67.80%-4.18M
-64.67%-13.97M
-59.93%-10.78M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 44.88%-20.6M88.79%-947K183.59%3.49M42.97%-7.97M-40.80%-15.18M-3.60%-37.37M-7.17%-8.45M67.80%-4.18M-64.67%-13.97M-59.93%-10.78M
Net income from continuing operations 22.38%-35.12M53.09%-3.64M59.02%-3.97M64.24%-5.22M-68.81%-22.29M4.71%-45.24M26.39%-7.76M-0.70%-9.68M-67.40%-14.6M29.01%-13.2M
Operating gains losses -174.51%-304K118.21%330K-100.40%-4K-137.96%-399K-230.51%-231K266.53%408K---1.81M1,355.70%992K1,336.47%1.05M318.52%177K
Other non cash items -8.58%405K-23.68%87K-23.21%86K0.92%110K12.96%122K-96.22%443K--114K--112K--109K-99.08%108K
Change In working capital 1,692.38%3.76M393.60%1.42M177.81%7.47M-11.24%-2.67M-705.42%-2.46M105.03%210K-139.67%-484K158.58%2.69M-230.40%-2.4M656.16%406K
-Change in prepaid assets 679.89%7.37M663.50%1.54M1,648.01%6.61M-3.19%-809K-98.97%25K109.21%945K-132.50%-274K94.15%-427K76.45%-784K605.20%2.43M
-Change in payables and accrued expense -1,346.93%-3.3M98.47%-2K49.24%-633K-278.97%-1.32M-425.67%-1.35M-106.48%-228K-129.77%-131K-905.65%-1.25M-55.20%737K-73.47%413K
-Change in other current assets 291.67%115K-91.67%1K-63.42%1.64M81.52%-409K52.34%-1.12M-102.34%-60K117.14%12K58.90%4.49M-331.24%-2.21M-104.35%-2.35M
-Change in other current liabilities 5.59%-422K-34.07%-122K-16.80%-146K4.93%-135K78.65%-19K-6,485.71%-447K-1,400.00%-91K---125K---142K---89K
Cash from discontinued investing activities
Operating cash flow 44.88%-20.6M88.79%-947K183.59%3.49M42.97%-7.97M-40.80%-15.18M-3.60%-37.37M-7.17%-8.45M67.80%-4.18M-64.67%-13.97M-59.93%-10.78M
Investing cash flow
Cash flow from continuing investing activities 100.29%68.98M157.37%36.75M229.50%28.04M-110.21%-1.6M243.67%5.8M129.96%34.44M277.34%14.28M107.96%8.51M15.69M-4.04M
Net investment purchase and sale 100.29%68.98M157.37%36.75M229.50%28.04M-110.21%-1.6M243.67%5.8M129.96%34.44M277.34%14.28M107.96%8.51M--15.69M---4.04M
Cash from discontinued investing activities
Investing cash flow 100.29%68.98M157.37%36.75M229.50%28.04M-110.21%-1.6M243.67%5.8M129.96%34.44M277.34%14.28M107.96%8.51M--15.69M---4.04M
Financing cash flow
Cash flow from continuing financing activities 841K288K528K24K1K00000
Proceeds from stock option exercised by employees --841K--288K--528K--24K--1K--0--0--0--0--0
Cash from discontinued financing activities
Financing cash flow --841K--288K--528K--24K--1K--0--0--0--0--0
Net cash flow
Beginning cash position -7.11%43.59M59.56%57.35M-22.42%25.29M7.85%34.44M-7.11%43.59M129.03%46.92M-42.78%35.94M-67.23%32.6M-33.35%31.93M129.03%46.92M
Current changes in cash 1,780.54%49.22M519.13%36.09M639.62%32.06M-654.12%-9.54M36.69%-9.38M-111.18%-2.93M136.67%5.83M111.80%4.33M-96.66%1.72M-154.18%-14.81M
Effect of exchange rate changes 174.51%304K-118.21%-330K100.40%4K137.96%399K230.51%231K-266.53%-408K--1.81M-1,355.70%-992K-1,336.47%-1.05M-318.52%-177K
End cash Position 113.63%93.11M113.63%93.11M59.56%57.35M-22.42%25.29M7.85%34.44M-7.11%43.59M-7.11%43.59M-42.78%35.94M-67.23%32.6M-33.35%31.93M
Free cash flow 44.88%-20.6M88.79%-947K183.59%3.49M42.97%-7.97M-40.80%-15.18M-3.60%-37.37M-7.17%-8.45M67.80%-4.18M-64.67%-13.97M-59.93%-10.78M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-1.04%